Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-049133

Chief Financial Officer bought 10,000 shares at $29.65 ($296,492)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BJERKHOLT ERIC Chief Financial Officer 2023-09-11 Purchase +10,000 $29.65 $296,492 10,000 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $29.65 · $296,492

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BJERKHOLT ERIC Chief Financial Officer 2023-09-11 Grant or award · Stock Option (right to buy) +110,000 110,000 D: show line 2 in the form
BJERKHOLT ERIC Chief Financial Officer 2023-09-11 Grant or award · Restricted Stock Units +55,000 55,000 D: show line 3 in the form
Loading xslF345X05/doc4.xml…